Characterization of selective and potent PI3Kδ inhibitor (PI3KD-IN-015) for B-Cell malignances

PI3Kδ is predominately expressed in leukocytes and has been found overexpressed in B-cell related malignances such as CLL and AML. We have discovered a highly selective ATP competitive PI3Kd inhibitor PI3KD-IN-015, which exhibits a high selectivity among other PI3K isoforms in both biochemical assay...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaochuan, Wang, Aoli, Liang, Xiaofei, Chen, Cheng, Liu, Juanjuan, Zhao, Zheng, Wu, Hong, Deng, Yuanxin, Wang, Li, Wang, Beilei, Wu, Jiaxin, Liu, Feiyang, Fernandes, Stacey M., Adamia, Sophia, Stone, Richard M., Galinsky, Ilene A., Brown, Jennifer R., Griffin, James D., Zhang, Shanchun, Loh, Teckpeng, Zhang, Xin, Wang, Wenchao, Weisberg, Ellen L., Liu, Jing, Liu, Qingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078040/
https://www.ncbi.nlm.nih.gov/pubmed/27081697
http://dx.doi.org/10.18632/oncotarget.8702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078040/
https://www.ncbi.nlm.nih.gov/pubmed/27081697
http://dx.doi.org/10.18632/oncotarget.8702

Ejemplares similares